Table 2.
Interactions between AD GRS and lipid levels on AD status in up to 3039 FHS individuals.
| Lipid Interactor | N Cases | N Total | Beta | SE | pval |
|---|---|---|---|---|---|
| Continuous lipid level | |||||
| HDL-C | 156 | 2995 | 0.005 | 0.007 | 0.458 |
| LDL-C | 156 | 2995 | −0.002 | 0.002 | 0.366 |
| Log (triglycerides) | 157 | 3039 | −0.353 | 0.129 | 0.006 |
| Extreme lipid level categorized by sex-specific 5th-percentiles of NHANES data | |||||
| Low HDL-C | 156 | 3031 | 0.168 | 0.314 | 0.593 |
| High LDL-C | 156 | 2995 | −0.157 | 0.243 | 0.518 |
| High triglycerides | 157 | 3039 | −0.573 | 0.254 | 0.024 |
| Extreme lipid level categorized by ATP III clinical definitions | |||||
| Low HDL-C | 157 | 3040 | 0.011 | 0.224 | 0.960 |
| High LDL-C | 156 | 2995 | −0.043 | 0.303 | 0.887 |
| High triglycerides | 157 | 3039 | −0.655 | 0.223 | 0.003 |